These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 12789286)
41. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Xie QC; Hu YD; Wang LL; Chen ZT; Diao XW; Wang ZX; Guan HJ; Zhu B; Sun JG; Duan YZ; Chen FL; Nian WQ Colloids Surf B Biointerfaces; 2005 Dec; 46(3):188-96. PubMed ID: 16337111 [TBL] [Abstract][Full Text] [Related]
42. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948 [TBL] [Abstract][Full Text] [Related]
43. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613 [TBL] [Abstract][Full Text] [Related]
44. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred. Petronzelli F; Sollima D; Coppola G; Martini-Neri ME; Neri G; Genuardi M Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531 [TBL] [Abstract][Full Text] [Related]
45. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346 [TBL] [Abstract][Full Text] [Related]
46. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P; Zaravinos A; Zioga M; Spandidos DA Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278 [TBL] [Abstract][Full Text] [Related]
47. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. Brookes S; Rowe J; Ruas M; Llanos S; Clark PA; Lomax M; James MC; Vatcheva R; Bates S; Vousden KH; Parry D; Gruis N; Smit N; Bergman W; Peters G EMBO J; 2002 Jun; 21(12):2936-45. PubMed ID: 12065407 [TBL] [Abstract][Full Text] [Related]
48. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Sharp R; Recio JA; Jhappan C; Otsuka T; Liu S; Yu Y; Liu W; Anver M; Navid F; Helman LJ; DePinho RA; Merlino G Nat Med; 2002 Nov; 8(11):1276-80. PubMed ID: 12368906 [TBL] [Abstract][Full Text] [Related]
49. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956 [TBL] [Abstract][Full Text] [Related]
50. Upregulation of chicken p15INK4b at senescence and in the developing brain. Kim SH; Rowe J; Fujii H; Jones R; Schmierer B; Kong BW; Kuchler K; Foster D; Ish-Horowicz D; Peters G J Cell Sci; 2006 Jun; 119(Pt 12):2435-43. PubMed ID: 16720639 [TBL] [Abstract][Full Text] [Related]
51. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression. van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902 [TBL] [Abstract][Full Text] [Related]
52. Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia. Cividin M; Ayrault O; Sorel N; Séité P; Brizard F; Blanchet O; Mahon FX; Guilhot F; Larsen C; Chomel JC; Brizard A Leuk Res; 2006 Oct; 30(10):1273-8. PubMed ID: 16533530 [TBL] [Abstract][Full Text] [Related]
54. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636 [TBL] [Abstract][Full Text] [Related]
55. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475 [TBL] [Abstract][Full Text] [Related]
56. Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas. Kawada Y; Nakamura M; Ishida E; Shimada K; Oosterwijk E; Uemura H; Hirao Y; Chul KS; Konishi N Jpn J Cancer Res; 2001 Dec; 92(12):1293-9. PubMed ID: 11749694 [TBL] [Abstract][Full Text] [Related]
57. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression. Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M Oncogene; 2002 Aug; 21(38):5960-6. PubMed ID: 12185599 [TBL] [Abstract][Full Text] [Related]
59. Homozygous deletions of the INK4a/ARF locus in renal cell cancer. Kasahara T; Bilim V; Hara N; Takahashi K; Tomita Y Anticancer Res; 2006; 26(6B):4299-305. PubMed ID: 17201148 [TBL] [Abstract][Full Text] [Related]
60. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Wang Y; Zhang Z; Kastens E; Lubet RA; You M Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]